asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress



Overview | Agenda | Promotional Opportunities | Grantors & Exhibitors | Travel/Hotel/Visa
Registration | Admin | Speaking Proposals | Webcast Log In | Past Events | Contact Us | Home





FOURTH ASIA PACIFIC
PHARMACEUTICAL
COMPLIANCE CONGRESS
AND BEST PRACTICES
FORUM


ATTEND ONSITE
September 16 - 18, 2014
Intercontinental Shanghai
Pudong Hotel
Shanghai, China
WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months






KEYNOTE SPEAKERS

Shuting LI, MD
Head, GCP Center of Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, China

Abdul Luheshi, MBA
Vice President, Health Care Compliance, Johnson & Johnson, Former Co-chair, Asia Pacific Pharma Congress, London, UK

David Snow, MBA
President, China and Hong Kong, AstraZeneca, Shanghai, China

Veronique Toully, MBA, DVM
Managing Director, China, UCB, Shanghai, China

Kin Ping Tsang
Chair, International Alliance of Patients Organizations (IAPO), Founder, Retina Hong Kong, Past Chair, Alliance for Patients Mutual Help Organizations (APMHO), Hong Kong

Professor Huang Yong
Competition Law Center, University of International Business and Economics, Executive Vice Chair, Expert Consultation Group, Anti-Monopoly Committee, State Council, Peoples Republic of China, Beijing, China

Shirley Zhao, MBA
President, Allergan China, Shanghai, China

FEATURING PRECONFERENCE
  • Negotiating, Implementing, Managing, Auditing and Monitoring Third Party Relationships
PLENARY SESSIONS
  • Asia Pacific Pharma Congress Vision and Overview
  • Perspectives from the C-Suite: Ethical Business Practice
  • Asia Pacific Compliance Issues from a Global Perspective
  • Asia Pacific Stakeholders Roundtable: HCPs, Hospitals and Patients
  • Key Issues Overview/Mini Summit Preview
  • China’s Health System and How it is Being Reformed
  • The Chinese Anti-unfair Competition Law
  • Overview of Recent Chinese Laws and Regulations
  • Chinese Compliance Best Practices Roundtable
  • Enhancing the Professional Role of a Compliance Officer
  • Asia Pacific R&D and Clinical Trials Compliance
  • Third Party Relationships Roundtable
  • New Pharma Business Models
  • New Compliance Challenges

MINI SUMMITS
  • Training on Compliance and Ethics Basics: Program Basics
  • Hot Asia Pac Compliance Issues
  • Country Compliance Updates: Malaysia and Indochina
  • Building the Compliance Profession
  • Advanced Issues in Anticorruption Compliance
  • Training on Compliance and Ethics Basics: Core Compliance Risks
  • Country Compliance Updates: Myanmar, India and Indonesia
  • Investigations Updates
  • Public Procurement, Tendering, Reimbursement and Pricing Update
  • The Role of Forensics in Compliance
  • Training on Compliance and Ethics Basics: Evolving Issues, Rising Expectations
  • Compliance Best Practices
  • Country Compliance Updates: Korea, Japan and Taiwan
  • Social Media and Technology Tools for Compliance
  • Examining Compliance Practices of Multinational and Domestic Firms in Emerging Markets
AND POSTCONFERENCE
  • Understanding the Interaction of Business Strategy and Compliance: Raising the Role of Compliance in Firms
FEATURED FACULTY

Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore

Timothy Ayers, JD, MPH
Principal, Porzio, Bromberg & Newman, Morristown, NJ, USA

Cheryl Bai, Esq.
Associate General Counsel, Greater China, Allergan Inc., Shanghai, China

Mark Brown, LLB, MBA
Director, PwC, Singapore

Dane Chamorro
Managing Director, Control Risks South-east Asia, Singapore

Eugene Chen, Esq.
Partner, Shanghai Office, Hogan Lovells International LLP, Shanghai, China

Iona Cheng
Practice Leader, Integrity Risk Consulting, Greater China and North Asia, Shanghai, China

Kherk Ying Chew, Esq.
Managing Partner, Wong & Partners, An affiliate of Baker & McKenzie, Kuala Lumpur, Malaysia

Chester Chu, CPA, CFE, CGMA
Director, Fraud Investigation & Dispute Services, EY, Taipei, Taiwan

Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea

Yee Chung Seck, Esq.
Partner, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Socialist Republic of Vietnam

Sangeet Dalliwall, LLB, LLM
Director of Compliance, APAC, Carlson Wagonlit Travel, Singapore

Damjan P. DeNoble, JD, MA
Partner, Rubicon Strategy Group, Editor, Health Intel Asia, Seattle, WA, USA

Sanjay Dhawan
Pharma GRC Leader; Executive Director, Risk Advisory Services, PwC, Bangalore, India

Carole Ducrest, Esq.
Regional General Counsel, APAC, China, Japan, Merck KGaA, Singapore

Diva Duong
Vice President Compliance EMEA, Cegedim Relationship Management, Paris, France

Lars Eckerlein
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Beijing, China

Adrian Emch, LLM
Partner, Hogan Lovells International LLP, Beijing, China

James Finch, Esq.
Partner and Head of Myanmar Office, DFDL/Myanmar Thanlwin Legal Services Ltd., Yangon, Myanmar

Steven N. Gersten, Esq.
Vice President, Ethics & Compliance Officer, International and Global Marketing, AbbVie, Former Divisional Vice President and Associate General Counsel, Commercial Legal Operations, Abbott Laboratories, Chicago, IL, USA

Michelle Y.L. Gon, Esq.
Partner, Baker & McKenzie, Shanghai

Erinn Hutchinson
Partner, Advisory Services, PricewaterhouseCoopers Consultants (Shenzhen) Limited, Shanghai, China

Kitchrat Kontain, LLM, MBA
Managing Partner, South East Asia Law Office, Vientiane, Laos

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Cristopher Landrito, LIB
Regional Compliance Officer, APAC Group Compliance, Merck Pte. Ltd., Singapore

Dominique Laymand
Vice President Compliance & Ethics EMEA, (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, President, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Paris, France

Andy Leck, Esq.
Partner, Baker & McKenzie.Wong & Leow, Singapore

Lei Li, LLB, LLM
Partner, Sidley Austin LLP, Beijing, China

Scott Likens
Partner and Consulting, Information, and Analytics Lead China/Hong Kong, PwC, Hong Kong

Steffanie Lim-Ho
Head of Ethics & Compliance, Lilly China, Shanghai, China

Chia-Feng Lu, Esq.
Associate, Baker & McKenzie (Gaikokuho Joint Enterprise), Tokyo, Japan

Andrew Martin, Esq.
Principal, Baker & McKenzie, Wong & Leow, Singapore



Shawn McBride
Vice President & General Manager - Direct to Patient and Market Access, Cardinal Health, Shanghai, China

Clement Ngai, Esq.
Partner, Baker & McKenzie Shanghai Office, Shanghai, China

Sun Qiang
Deputy Dean, Assistant Professor, Center for Health Management and Policy, School of Public Health, Shandong University, Jinan, China




Teng Ren, MA
Head of Compliance, Asia-Pacific, Middle East, and Africa, Russia/Ukraine, Novartis, Former Compliance Director, Johnson & Johnson Medical China and Eli Lilly, Singapore

Brian Riewerts
Principal, Global Governance, Risk and Compliance Leader, Pharmaceutical and Life Sciences Advisory, PwC, Baltimore, MD, USA

Bretton G. Sciaroni, Esq.
Partner, Sciaroni & Associates, Phnom Penh, Cambodia

Clarissa SHEN, MBA
Country Compliance Officer, Global Compliance and Business Ethics, Sanofi, Shanghai, China

Arun Sharma, MBA, PhD
Professor and Executive Director, JAE Leadership Institute, School of Business Administration, University of Miami, Miami, FL, USA

Diana Shin
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China

Benjamin Shobert, MBA
Partner and Founder, Rubicon Strategy Group, Seattle, WA

Rhys Tee
Associate Director, Compliance (APAC), Allergan, Singapore

John Tsai
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China

Peerapan Tungsuwan
Partner and Lead, Asia-Pacific Regional Pharmaceuticals and Healthcare Group, Baker & McKenzie Ltd., Bangkok, Thailand

Emmanuel Vignal
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China

Kevin Y. H. Wang, LLM
Senior Consultant, Baker & McKenzie, Taipei, Taipei, Taiwan

Wimbanu Widyatmoko, LLM
Partner, Hadiputranto, Hadinoto & Partners, An affiliate of Baker & McKenzie, Jakarta, Indonesia

Wendy L. Wysong, Esq.
Partner, Clifford Chance LLP, Former Assistant US Attorney, Washington, DC, Former Deputy Assistant Secretary for Export Enforcement, Bureau of Industry & Security, UA Department of Commerce, Hong Kong and Washington, DC, USA

Chen Yang, Esq.
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China

Shine Yao, MIM
China Compliance Director, Merck Sharp & Dohme, Shanghai, China

Eva Yin
Vice President, Commercial AstraZeneca China, Former China/HK Compliance Officer, AstraZeneca, Shanghai, China

Eric Young
Forensic Technology Partner, EY, Hong Kong

Bing Yu, LLB, LLM
Of Counsel, Clifford Chance LLP, Shanghai, China

Zhu Yuanyuan, LLM
Partner, King & Wood Malleson, Beijing, China

Liu Xiangwen, LLM
Partner, King & Wood Malleson, Former Staff, Legislative Affairs Commission, Standing Committee, National People's Congress, Beijing, China

Stella Zhu, LLM
Senior Counsel, Asia Pacific for R&D, Allergan, Shanghai, China


EARLY BIRD REGISTRATION
- SAVE UP TO $300 -
Register by Friday, August 22, 2014 for Early Bird discount. Save up to $300.
Click here to register.

BROCHURE NOW AVAILABLE
Click here to download the brochure.
SPONSORED BY:


The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.

COSPONSORED BY:


The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.


The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.




CO CHAIRS

Maija Burtmanis, LLB, LLM
Regional Compliance Director, Asia, Australia, Africa, Middle East & Japan, AbbVie, Singapore

Karen Eryou
Senior Director, Corporate Compliance APAC, UCB Pharma, Shanghai, China

Gareth Lee, Esq.
General Counsel and Head of Compliance, Asia Pacific, Allergan Inc., Singapore

Maria "Maru" Quindimil, MBA
Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dhome (Asia Ltd.), Manila, Philippines

GRANTORS:
DIAMOND


PLATINUM


BRONZE














MEDIA PARTNER


OTHER INTERNATIONAL PHARMA CONGRESSES


2007 - Brussels, Belgium


2008 - Paris, France


2009 - Rome, Italy


2010 - Berlin, Germany


2011 - Istanbul, Turkey


2011 - Singapore


2012 - Budapest, Hungary


2012 - Shanghai, China


2012 - São Paulo, Brazil


2013 - Madrid, Spain


2013 - Kuala Lumpur, Malaysia


2014 - Dubai, United Arab Emirates


2014 - Mexico City, Mexico




FOURTH ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS AND BEST PRACTICES FORUM

September 16 - 18, 2014

ATTEND ONSITE
Intercontinental Shanghai Pudong Hotel
Shanghai, China


OR
WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months


SAVE THE DATES

SEVENTH INTERNATIONAL PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 5 - 7, 2014
Conrad Dubai
Dubai, United Arab Emirates
www.InternationalPharmaCongress.com
SECOND LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Latin American Ethics and Compliance Network
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
July 28 - 31, 2014
Mexico City, Mexico
www.LatinAmericanPharmaCongress.com
FIFTEENTH PHARMACEUTICAL REGULATORY
AND COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
November 3 - 5, 2014
Hyatt Regency on Capitol Hill
Washington, DC
www.PharmaCongress.com

PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction





We subscribe to the HONcode principles of the HON Foundation. Click to verify.




LIVE AND ARCHIVED WEBCAST ATTENDANCE
Watch the conference in live streaming video of plenary sessions and listen to audio of preconference and track sessions over the Internet and at your convenience at any time 24/7 for six months following the event.

The archived conference includes speaker Video and Audio and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for the next six months; accessible in the office, at home or anywhere worldwide with Internet access; avoid travel expense and hassle; no time away from the office.





WEBCAST INTERFACE SAMPLE

Click here for a sample stream

THE 2013 THIRD ASIA PACIFIC PHARMA CONGRESS CONTENT IS NOW AVAILABLE
IN VARIOUS POST CONFERENCE FORMATS

The 2013 Third Asia Pacific Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE ASIA PACIFIC PHARMA CONGRESS CONTENT AS FOLLOWS:

Online Archive of 2013 Third Asia Pacific Pharma Congress Presentations today!
Complete conference: $595
Order Now

Flash Drive of 2013 Third Asia Pacific Pharma Congress Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE ASIA PACIFIC PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).




Overview | Agenda | Promotional Opportunities | Grantors & Exhibitors | Travel/Hotel/Visa
Registration | Admin | Speaking Proposals | Webcast Log In | Past Events | Contact Us | Home




© Health Care Conference Administrators
Contact Webmaster